HIMSS APAC 2025: Malaysian Health Minister Visits GuidelineX Exhibition
- nabalunews
- Jul 23
- 2 min read
23 July 2025
KUALA LUMPUR: Dr. Dzulkefly Ahmad, Malaysia’s Minister of Health, paid a visit to the GuidelineX exhibition at HIMSS APAC 2025, where he engaged in in-depth discussions concerning AI-powered clinical decision support systems (CDSS).
The Minister examined the practical applications of GuidelineX’s technology, which has supported 61 million inpatient visits and facilitated 1.4 billion outpatient visits annually across China — representing approximately 25% of inpatient and 33% of outpatient hospital visits nationwide.
Dr. Ahmad highlighted Malaysia’s ongoing initiatives in digital health and expressed keen interest in GuidelineX’s reported outcomes. These include a 46% reduction in hospital-acquired venous thromboembolism (HA-VTE) rates, achieved through AI-based alerting systems.
Notably, GuidelineX’s AI screened 10,233 individuals for Fabry disease within just three months, successfully identifying five confirmed cases and two individuals with GLA gene variants of uncertain significance (VUS). This exemplifies the tremendous potential of AI-CDSS in promoting early detection and advancing population health strategies. “To succeed, we must look both inward and outward,” stated Dr. Ahmad, emphasising that digital health transformation involves “more than just deploying systems — it requires a holistic approach to innovation and patient care.”
As a leading provider of AI clinical adoption solutions in Asia, GuidelineX offers next-generation, cloud-native systems that, by the end of 2024, have been implemented in 1,061 large hospitals, including 50% of the country’s top 100 major hospitals.
Dr. Jenny Shao, Chief Medical Officer of GuidelineX, showcased the company’s AI applications in chronic disease management and oncology clinical pathways. The Minister acknowledged the significant potential of AI to enhance healthcare delivery.
GuidelineX positions AI as an intelligent, specialised assistant seamlessly integrated into clinical workflows, rather than a rigid tool requiring extensive adaptation by physicians. This philosophy has driven its product ecosystem to deliver actionable clinical AI recommendations, which clinicians worldwide adopt over 1 billion times annually. The Minister expressed strong support for this vision during the demonstration.
Caption: Malaysia’s Minister of Health, Dr. Dzulkefly Ahmad, visiting the GuidelineX booth.
It’s encouraging to see healthcare innovation highlighted at events like HIMSS APAC 2025, as it shows a commitment to improving patient outcomes and system efficiency. Equally important is addressing ongoing public health challenges, such as substance use. Facilities like a private rehab play a vital role in providing specialized, compassionate care for those struggling with addiction while complementing broader health initiatives showcased at such exhibitions.